Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.
Latest news
Colli-Pee® Small Volumes Products CE Marked
31/07/2020
Novosanis achieved two major milestones - our Colli-Pee ® Small Volumes product line is now CE-Marked.
Latest blogpost
Upcoming event
Webinar: Accuracy and Validation of pre-analytical and analytical procedures for HPV and STIs testing of self-collected urine samples
Virtual webinar
Register now for an upcoming webinar hosted by Novosanis with Prof. Clementina Cocuzza and Prof. Alex Vorsters, which will highlight the potential of self-collected urine samples for detection of STIs, including Human Papillomavirus (HPV).